Nyxoah posts preliminary Q2 2026 revenue of €7.7 million, keeps full-year outlook
The medtech company said U.S. launch momentum lifted sales, while CMS proposed 12% and 15% reimbursement increases for the Genio procedure in hospital outpatient and ASC settings.